STRIDES PHARMA SCIENCE Financial Statement Analysis
|
||
The Revenues of STRIDES PHARMA SCIENCE have increased by 9.83% YoY .
The Earnings Per Share (EPS) of STRIDES PHARMA SCIENCE has decreased by Negative YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
STRIDES PHARMA SCIENCE Last 5 Annual Financial Results
[BOM: 532531|NSE : STAR]
Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
---|---|---|---|---|---|
Revenues | ₹4,051 Cr | ₹3,688 Cr | ₹3,070 Cr | ₹3,316 Cr | ₹2,752 Cr |
Expenses | ₹3,318 Cr | ₹3,303 Cr | ₹3,092 Cr | ₹2,689 Cr | ₹2,236 Cr |
Operating Profit (Excl OI) | ₹733 Cr | ₹385 Cr | ₹-22 Cr | ₹627 Cr | ₹516 Cr |
Other Income | ₹50 Cr | ₹135 Cr | ₹133 Cr | ₹59 Cr | ₹53 Cr |
Interest | ₹314 Cr | ₹261 Cr | ₹177 Cr | ₹150 Cr | ₹156 Cr |
Depreciation | ₹221 Cr | ₹243 Cr | ₹233 Cr | ₹206 Cr | ₹174 Cr |
Profit Before Tax | ₹-117 Cr | ₹-286 Cr | ₹-653 Cr | ₹275 Cr | ₹55 Cr |
Profit After Tax | ₹-149 Cr | ₹-231 Cr | ₹-474 Cr | ₹244 Cr | ₹43 Cr |
Consolidated Net Profit | ₹-71 Cr | ₹-203 Cr | ₹-460 Cr | ₹268 Cr | ₹36 Cr |
Earnings Per Share (Rs) | ₹-7.68 | ₹-22.44 | ₹-51.25 | ₹29.93 | ₹4.06 |
PAT Margin (%) | -2.38 | -3.70 | -8.90 | 4.45 | 0.92 |
ROE(%) | -6.88 | -10.15 | -18.49 | 9.21 | 1.68 |
ROCE(%) | 4.15 | -0.49 | -9.49 | 9.08 | 4.06 |
Total Debt/Equity(x) | 1.14 | 1.27 | 1.18 | 0.76 | 0.78 |
Key Financials |
||
Market Cap | : | ₹ 8,045.4 Cr |
Revenue (TTM) | : | ₹ 4,632.7 Cr |
Net Profit(TTM) | : | ₹ 358.2 Cr |
EPS (TTM) | : | ₹ 38.8 |
P/E (TTM) | : | 22.5 |
Industry Peers & Returns | 1W | 1M | 1Y |
STRIDES PHARMA SCIENCE | -1.2% | 6.4% | -7.5% |
SUN PHARMACEUTICAL INDUSTRIES | -0.7% | -1.3% | 6.6% |
DIVIS LABORATORIES | 1.8% | 4.8% | 49.8% |
CIPLA | -1.1% | -1.3% | -1.4% |
TORRENT PHARMACEUTICALS | 0.6% | 4.2% | 15.1% |
DR REDDYS LABORATORIES | -1.8% | -6% | -1.6% |
MANKIND PHARMA | 6.9% | 6.2% | 13.7% |
ZYDUS LIFESCIENCES | -2.1% | -0.3% | -15.4% |
LUPIN | -2.2% | -4.7% | 8.6% |
STRIDES PHARMA SCIENCE Revenues
[BOM: 532531|NSE : STAR]
Y-o-Y | 9.83 % |
5 Yr CAGR | 10.15 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2024 | ₹4,051 Cr | 9.83 | |
Mar2023 | ₹3,688 Cr | 20.13 | |
Mar2022 | ₹3,070 Cr | -7.41 | |
Mar2021 | ₹3,316 Cr | 20.49 | |
Mar2020 | ₹2,752 Cr | - |
STRIDES PHARMA SCIENCE Operating Profit
[BOM: 532531|NSE : STAR]
Y-o-Y | 90.27 % |
5 Yr CAGR | 9.18 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹733 Cr | 90.27 | |
Mar2023 | ₹385 Cr | Positive | |
Mar2022 | ₹-22 Cr | Negative | |
Mar2021 | ₹627 Cr | 21.50 | |
Mar2020 | ₹516 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 73.21 % |
5 Yr CAGR | -0.88 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2024 | 18.1% | 73.21 | |
Mar2023 | 10.45% | Positive | |
Mar2022 | -0.7% | Negative | |
Mar2021 | 18.9% | 0.80 | |
Mar2020 | 18.75% | - |
STRIDES PHARMA SCIENCE Profit After Tax
[BOM: 532531|NSE : STAR]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹-71 Cr | Negative | |
Mar2023 | ₹-203 Cr | Negative | |
Mar2022 | ₹-460 Cr | Negative | |
Mar2021 | ₹268 Cr | 637.66 | |
Mar2020 | ₹36 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2024 | -2.38 % | Negative | |
Mar2023 | -3.7 % | Negative | |
Mar2022 | -8.9 % | Negative | |
Mar2021 | 4.45 % | 383.70 | |
Mar2020 | 0.92 % | - |
STRIDES PHARMA SCIENCE Earnings Per Share (EPS)
[BOM: 532531|NSE : STAR]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | EPS | % Change | |
---|---|---|---|
Mar2024 | ₹-7.68 | Negative | |
Mar2023 | ₹-22 | Negative | |
Mar2022 | ₹-51 | Negative | |
Mar2021 | ₹30 | 637.19 | |
Mar2020 | ₹4.06 | - |
STRIDES PHARMA SCIENCE Return on Capital Employed (ROCE)
[BOM: 532531|NSE : STAR]
Y-o-Y | Positive |
5 Yr CAGR | 0.55 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2024 | 4.15% | Positive | |
Mar2023 | -0.49% | Negative | |
Mar2022 | -9.49% | Negative | |
Mar2021 | 9.08% | 123.65 | |
Mar2020 | 4.06% | - |
STRIDES PHARMA SCIENCE Share Price vs Sensex
Current Share Price | : | ₹872.6 |
Current MarketCap | : | ₹ 8,045.4 Cr |
Updated EOD on | : | Jul 09,2025 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
STRIDES PHARMA SCIENCE | -1.2% |
6.4% |
-7.5% |
SENSEX | 0.2% |
1.3% |
4.4% |
STRIDES PHARMA SCIENCE related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
BSE ALLCAP | 6.4% | 8.9% | 7.5% |
BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
BSE SMALLCAP | 0.6% | 1.4% | 1.9% |
BSE HEALTHCARE | 0.5% | 2.3% | 17.5% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY MIDSMALL HEALTHCARE | 0.6% | 3.7% | 20.6% |
NIFTY MICROCAP 250 | 0.4% | 1.1% | 1.7% |
NIFTY TOTAL MARKET | 0.1% | 1% | 2.8% |
You may also like the below Video Courses
FAQ about STRIDES PHARMA SCIENCE Financials
How the annual revenues of STRIDES PHARMA SCIENCE have changed ?
The Revenues of STRIDES PHARMA SCIENCE have increased by 9.83% YoY .
How the Earnings per Share (EPS) of STRIDES PHARMA SCIENCE have changed?
The Earnings Per Share (EPS) of STRIDES PHARMA SCIENCE has decreased by Negative YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs